APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Zoste Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Herpes Zoste Drug Industry Growth and Trends Forecast to 2032

26 December 2025104 pages

Choose your research edition.

Industry ResearchHerpes Zoste Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Zoste Drug Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Herpes Zoste Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Zoste Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Zoste Drug Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Herpes Zoste Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Zoste Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Herpes Zoste Drug include Merck & Co., Inc., Beijing Minhai Biotechnology Co., Ltd, Astellas Pharma Inc., TSRL, Inc., ReceptoPharm, Inc., NAL Pharmaceuticals Ltd., GlaxoSmithKline Plc, GeneOne Life Science, Inc. and Foamix Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Herpes Zoste Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Herpes Zoste Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Herpes Zoste Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Herpes Zoste Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Herpes Zoste Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Herpes Zoste Drug Market by Company

Merck & Co., Inc.

Beijing Minhai Biotechnology Co., Ltd

Astellas Pharma Inc.

TSRL, Inc.

ReceptoPharm, Inc.

NAL Pharmaceuticals Ltd.

GlaxoSmithKline Plc

GeneOne Life Science, Inc.

Foamix Pharmaceuticals Ltd.

Epiphany Biosciences, Inc.

ContraVir Pharmaceuticals, Inc.

Herpes Zoste Drug Segment by Type

FV-100

GLS-5100

GSK-1437173A

NAL-3221

Amenamevir

Acyclovir

Others

Herpes Zoste Drug Segment by Application

Clinic

Hospital

Others

Herpes Zoste Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Zoste Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Zoste Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Zoste Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Herpes Zoste Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Herpes Zoste Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of FV-100 Table 2. Major Company of GLS-5100 Table 3. Major Company of GSK-1437173A Table 4. Major Company of NAL-3221 Table 5. Major Company of Amenamevir Table 6. Major Company of Acyclovir Table 7. Major Company of Others Table 8. Global Herpes Zoste Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 10. Global Herpes Zoste Drug Sales Market Share in Volume by Type (2021-2026) Table 11. Global Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 12. Global Herpes Zoste Drug Sales Market Share in Value by Type (2021-2026) Table 13. Global Herpes Zoste Drug Price by Type (2021-2026) & (US$/Unit) Table 14. Global Herpes Zoste Drug Sales by Type (2027-2032) & (W Units) Table 15. Global Herpes Zoste Drug Sales Market Share in Volume by Type (2027-2032) Table 16. Global Herpes Zoste Drug Sales by Type (2027-2032) & (US$ Million) Table 17. Global Herpes Zoste Drug Sales Market Share in Value by Type (2027-2032) Table 18. Global Herpes Zoste Drug Price by Type (2027-2032) & (US$/Unit) Table 19. North America Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 20. North America Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 22. Europe Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 24. Asia-Pacific Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 26. Latin America Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Herpes Zoste Drug Sales by Type (2021-2026) & (W Units) Table 28. Middle East and Africa Herpes Zoste Drug Sales by Type (2021-2026) & (US$ Million) Table 29. Herpes Zoste Drug Industry Trends Table 30. Herpes Zoste Drug Industry Drivers Table 31. Herpes Zoste Drug Industry Opportunities and Challenges Table 32. Herpes Zoste Drug Industry Restraints Table 33. Global Herpes Zoste Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Herpes Zoste Drug Revenue Market Share by Company (2021-2026) Table 35. Global Herpes Zoste Drug Sales by Company (2021-2026) & (W Units) Table 36. Global Herpes Zoste Drug Sales Share by Company (2021-2026) Table 37. Global Herpes Zoste Drug Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Herpes Zoste Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Herpes Zoste Drug Major Company Production Sites and Headquarters Table 40. Global Herpes Zoste Drug Company, Product Type & Application Table 41. Global Herpes Zoste Drug Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Herpes Zoste Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Herpes Zoste Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Herpes Zoste Drug Sales by Region (2021-2026) & (W Units) Table 46. Global Herpes Zoste Drug Sales Market Share in Volume by Region (2021-2026) Table 47. Global Herpes Zoste Drug Sales by Region (2021-2026) & (US$ Million) Table 48. Global Herpes Zoste Drug Sales Market Share in Value by Region (2021-2026) Table 49. Global Herpes Zoste Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Herpes Zoste Drug Sales by Region (2027-2032) & (W Units) Table 51. Global Herpes Zoste Drug Sales Market Share in Volume by Region (2027-2032) Table 52. Global Herpes Zoste Drug Sales by Region (2027-2032) & (US$ Million) Table 53. Global Herpes Zoste Drug Sales Market Share in Value by Region (2027-2032) Table 54. Global Herpes Zoste Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Herpes Zoste Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 57. Global Herpes Zoste Drug Sales Market Share in Volume by Application (2021-2026) Table 58. Global Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 59. Global Herpes Zoste Drug Sales Market Share in Value by Application (2021-2026) Table 60. Global Herpes Zoste Drug Price by Application (2021-2026) & (US$/Unit) Table 61. Global Herpes Zoste Drug Sales by Application (2027-2032) & (W Units) Table 62. Global Herpes Zoste Drug Sales Market Share in Volume by Application (2027-2032) Table 63. Global Herpes Zoste Drug Sales by Application (2027-2032) & (US$ Million) Table 64. Global Herpes Zoste Drug Sales Market Share in Value by Application (2027-2032) Table 65. Global Herpes Zoste Drug Price by Application (2027-2032) & (US$/Unit) Table 66. North America Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 67. North America Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 69. Europe Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 71. Asia-Pacific Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 73. Latin America Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Herpes Zoste Drug Sales by Application (2021-2026) & (W Units) Table 75. Middle East and Africa Herpes Zoste Drug Sales by Application (2021-2026) & (US$ Million) Table 76. Merck & Co., Inc. Company Information Table 77. Merck & Co., Inc. Business Overview Table 78. Merck & Co., Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Merck & Co., Inc. Herpes Zoste Drug Product Portfolio Table 80. Merck & Co., Inc. Recent Development Table 81. Beijing Minhai Biotechnology Co., Ltd Company Information Table 82. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 83. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio Table 85. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 86. Astellas Pharma Inc. Company Information Table 87. Astellas Pharma Inc. Business Overview Table 88. Astellas Pharma Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio Table 90. Astellas Pharma Inc. Recent Development Table 91. TSRL, Inc. Company Information Table 92. TSRL, Inc. Business Overview Table 93. TSRL, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. TSRL, Inc. Herpes Zoste Drug Product Portfolio Table 95. TSRL, Inc. Recent Development Table 96. ReceptoPharm, Inc. Company Information Table 97. ReceptoPharm, Inc. Business Overview Table 98. ReceptoPharm, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio Table 100. ReceptoPharm, Inc. Recent Development Table 101. NAL Pharmaceuticals Ltd. Company Information Table 102. NAL Pharmaceuticals Ltd. Business Overview Table 103. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 105. NAL Pharmaceuticals Ltd. Recent Development Table 106. GlaxoSmithKline Plc Company Information Table 107. GlaxoSmithKline Plc Business Overview Table 108. GlaxoSmithKline Plc Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio Table 110. GlaxoSmithKline Plc Recent Development Table 111. GeneOne Life Science, Inc. Company Information Table 112. GeneOne Life Science, Inc. Business Overview Table 113. GeneOne Life Science, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio Table 115. GeneOne Life Science, Inc. Recent Development Table 116. Foamix Pharmaceuticals Ltd. Company Information Table 117. Foamix Pharmaceuticals Ltd. Business Overview Table 118. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio Table 120. Foamix Pharmaceuticals Ltd. Recent Development Table 121. Epiphany Biosciences, Inc. Company Information Table 122. Epiphany Biosciences, Inc. Business Overview Table 123. Epiphany Biosciences, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio Table 125. Epiphany Biosciences, Inc. Recent Development Table 126. ContraVir Pharmaceuticals, Inc. Company Information Table 127. ContraVir Pharmaceuticals, Inc. Business Overview Table 128. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio Table 130. ContraVir Pharmaceuticals, Inc. Recent Development Table 131. North America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. North America Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 133. North America Herpes Zoste Drug Sales Market Share by Country (2021-2026) Table 134. North America Herpes Zoste Drug Sales Forecast by Country (2027-2032) & (W Units) Table 135. North America Herpes Zoste Drug Sales Market Share Forecast by Country (2027-2032) Table 136. North America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Herpes Zoste Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Herpes Zoste Drug Market Share by Country (2021-2026) Table 139. North America Herpes Zoste Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Herpes Zoste Drug Market Share Forecast by Country (2027-2032) Table 141. Europe Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Europe Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 143. Europe Herpes Zoste Drug Sales Market Share by Country (2021-2026) Table 144. Europe Herpes Zoste Drug Sales Forecast by Country (2027-2032) & (W Units) Table 145. Europe Herpes Zoste Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Herpes Zoste Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Herpes Zoste Drug Market Share by Country (2021-2026) Table 149. Europe Herpes Zoste Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Herpes Zoste Drug Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 153. Asia-Pacific Herpes Zoste Drug Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Herpes Zoste Drug Sales Forecast by Country (2027-2032) & (W Units) Table 155. Asia-Pacific Herpes Zoste Drug Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Herpes Zoste Drug Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Herpes Zoste Drug Market Share by Country (2021-2026) Table 159. Asia-Pacific Herpes Zoste Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Herpes Zoste Drug Market Share Forecast by Country (2027-2032) Table 161. Latin America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Latin America Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 163. Latin America Herpes Zoste Drug Sales Market Share by Country (2021-2026) Table 164. Latin America Herpes Zoste Drug Sales Forecast by Country (2027-2032) & (W Units) Table 165. Latin America Herpes Zoste Drug Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Herpes Zoste Drug Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Herpes Zoste Drug Market Share by Country (2021-2026) Table 169. Latin America Herpes Zoste Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Herpes Zoste Drug Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Herpes Zoste Drug Sales by Country (2021-2026) & (W Units) Table 173. Middle East and Africa Herpes Zoste Drug Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Herpes Zoste Drug Sales Forecast by Country (2027-2032) & (W Units) Table 175. Middle East and Africa Herpes Zoste Drug Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Herpes Zoste Drug Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Herpes Zoste Drug Market Share by Country (2021-2026) Table 179. Middle East and Africa Herpes Zoste Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Herpes Zoste Drug Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Herpes Zoste Drug Distributors List Table 184. Herpes Zoste Drug Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Herpes Zoste Drug Image Figure 2. Global Herpes Zoste Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Zoste Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Herpes Zoste Drug Sales (2021-2032) & (W Units) Figure 5. FV-100 Image Figure 6. Global FV-100 Sales YoY Growth (2021-2032) & (W Units) Figure 7. GLS-5100 Image Figure 8. Global GLS-5100 Sales YoY Growth (2021-2032) & (W Units) Figure 9. GSK-1437173A Image Figure 10. Global GSK-1437173A Sales YoY Growth (2021-2032) & (W Units) Figure 11. NAL-3221 Image Figure 12. Global NAL-3221 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Amenamevir Image Figure 14. Global Amenamevir Sales YoY Growth (2021-2032) & (W Units) Figure 15. Acyclovir Image Figure 16. Global Acyclovir Sales YoY Growth (2021-2032) & (W Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 19. Global Herpes Zoste Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Herpes Zoste Drug Market Share by Type 2025 VS 2032 Figure 21. North America Herpes Zoste Drug Sales Market Share in Volume by Type in 2025 Figure 22. North America Herpes Zoste Drug Sales Market Share in Value by Type in 2025 Figure 23. Europe Herpes Zoste Drug Sales Market Share in Volume by Type in 2025 Figure 24. Europe Herpes Zoste Drug Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Type in 2025 Figure 27. Latin America Herpes Zoste Drug Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Herpes Zoste Drug Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Herpes Zoste Drug Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Herpes Zoste Drug Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 35. Hospital Image Figure 36. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 39. Global Herpes Zoste Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Herpes Zoste Drug Market Share by Application 2025 VS 2032 Figure 41. North America Herpes Zoste Drug Sales Market Share in Volume by Application in 2025 Figure 42. North America Herpes Zoste Drug Sales Market Share in Value by Application in 2025 Figure 43. Europe Herpes Zoste Drug Sales Market Share in Volume by Application in 2025 Figure 44. Europe Herpes Zoste Drug Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Herpes Zoste Drug Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Herpes Zoste Drug Sales Market Share in Value by Application in 2025 Figure 47. Latin America Herpes Zoste Drug Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Herpes Zoste Drug Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Herpes Zoste Drug Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Herpes Zoste Drug Sales Market Share in Value by Application in 2025 Figure 51. North America Herpes Zoste Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. North America Herpes Zoste Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Herpes Zoste Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Herpes Zoste Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Herpes Zoste Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Europe Herpes Zoste Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Herpes Zoste Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Herpes Zoste Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Herpes Zoste Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Asia-Pacific Herpes Zoste Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Herpes Zoste Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Herpes Zoste Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Herpes Zoste Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Latin America Herpes Zoste Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Herpes Zoste Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Herpes Zoste Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Herpes Zoste Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 68. Middle East and Africa Herpes Zoste Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Herpes Zoste Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Herpes Zoste Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Herpes Zoste Drug Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Herpes Zoste Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • FV-100
  • GLS-5100
  • GSK-1437173A
  • NAL-3221
  • Amenamevir
  • Acyclovir
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Merck & Co., Inc.
  • Beijing Minhai Biotechnology Co., Ltd
  • Astellas Pharma Inc.
  • TSRL, Inc.
  • ReceptoPharm, Inc.
  • NAL Pharmaceuticals Ltd.
  • GlaxoSmithKline Plc
  • GeneOne Life Science, Inc.
  • Foamix Pharmaceuticals Ltd.
  • Epiphany Biosciences, Inc.
  • ContraVir Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Zoste Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Herpes Zoste Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Herpes Zoste Drug Market by Type
  6. 1.3.1 FV-100
  7. 1.3.2 GLS-5100
  8. 1.3.3 GSK-1437173A
  9. 1.3.4 NAL-3221
  10. 1.3.5 Amenamevir
  11. 1.3.6 Acyclovir
  12. 1.3.7 Others
  13. 1.4 Global Herpes Zoste Drug Market Size by Type
  14. 1.4.1 Global Herpes Zoste Drug Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Herpes Zoste Drug Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Herpes Zoste Drug Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Herpes Zoste Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Herpes Zoste Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Herpes Zoste Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Herpes Zoste Drug Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Herpes Zoste Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Herpes Zoste Drug Industry Trends
  2. 2.2 Herpes Zoste Drug Industry Drivers
  3. 2.3 Herpes Zoste Drug Industry Opportunities and Challenges
  4. 2.4 Herpes Zoste Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Herpes Zoste Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Herpes Zoste Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Herpes Zoste Drug Price (2021-2026)
  4. 3.4 Global Herpes Zoste Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Herpes Zoste Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Herpes Zoste Drug Company, Product Type & Application
  7. 3.7 Global Herpes Zoste Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Herpes Zoste Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Herpes Zoste Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Herpes Zoste Drug Tier 1, Tier 2, and Tier 3
4 Herpes Zoste Drug Regional Status and Outlook
  1. 4.1 Global Herpes Zoste Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Herpes Zoste Drug Historic Market Size by Region
  3. 4.2.1 Global Herpes Zoste Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Herpes Zoste Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Herpes Zoste Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Herpes Zoste Drug Forecasted Market Size by Region
  7. 4.3.1 Global Herpes Zoste Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Herpes Zoste Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Herpes Zoste Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Herpes Zoste Drug by Application
  1. 5.1 Herpes Zoste Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Herpes Zoste Drug Market Size by Application
  6. 5.2.1 Global Herpes Zoste Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Herpes Zoste Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Herpes Zoste Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Herpes Zoste Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Herpes Zoste Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Herpes Zoste Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Herpes Zoste Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Herpes Zoste Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Herpes Zoste Drug Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Beijing Minhai Biotechnology Co., Ltd
  8. 6.2.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  9. 6.2.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  10. 6.2.3 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Product Portfolio
  12. 6.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  13. 6.3 Astellas Pharma Inc.
  14. 6.3.1 Astellas Pharma Inc. Company Information
  15. 6.3.2 Astellas Pharma Inc. Business Overview
  16. 6.3.3 Astellas Pharma Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Astellas Pharma Inc. Herpes Zoste Drug Product Portfolio
  18. 6.3.5 Astellas Pharma Inc. Recent Developments
  19. 6.4 TSRL, Inc.
  20. 6.4.1 TSRL, Inc. Company Information
  21. 6.4.2 TSRL, Inc. Business Overview
  22. 6.4.3 TSRL, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 TSRL, Inc. Herpes Zoste Drug Product Portfolio
  24. 6.4.5 TSRL, Inc. Recent Developments
  25. 6.5 ReceptoPharm, Inc.
  26. 6.5.1 ReceptoPharm, Inc. Company Information
  27. 6.5.2 ReceptoPharm, Inc. Business Overview
  28. 6.5.3 ReceptoPharm, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 ReceptoPharm, Inc. Herpes Zoste Drug Product Portfolio
  30. 6.5.5 ReceptoPharm, Inc. Recent Developments
  31. 6.6 NAL Pharmaceuticals Ltd.
  32. 6.6.1 NAL Pharmaceuticals Ltd. Company Information
  33. 6.6.2 NAL Pharmaceuticals Ltd. Business Overview
  34. 6.6.3 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  36. 6.6.5 NAL Pharmaceuticals Ltd. Recent Developments
  37. 6.7 GlaxoSmithKline Plc
  38. 6.7.1 GlaxoSmithKline Plc Company Information
  39. 6.7.2 GlaxoSmithKline Plc Business Overview
  40. 6.7.3 GlaxoSmithKline Plc Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Product Portfolio
  42. 6.7.5 GlaxoSmithKline Plc Recent Developments
  43. 6.8 GeneOne Life Science, Inc.
  44. 6.8.1 GeneOne Life Science, Inc. Company Information
  45. 6.8.2 GeneOne Life Science, Inc. Business Overview
  46. 6.8.3 GeneOne Life Science, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GeneOne Life Science, Inc. Herpes Zoste Drug Product Portfolio
  48. 6.8.5 GeneOne Life Science, Inc. Recent Developments
  49. 6.9 Foamix Pharmaceuticals Ltd.
  50. 6.9.1 Foamix Pharmaceuticals Ltd. Company Information
  51. 6.9.2 Foamix Pharmaceuticals Ltd. Business Overview
  52. 6.9.3 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Product Portfolio
  54. 6.9.5 Foamix Pharmaceuticals Ltd. Recent Developments
  55. 6.10 Epiphany Biosciences, Inc.
  56. 6.10.1 Epiphany Biosciences, Inc. Company Information
  57. 6.10.2 Epiphany Biosciences, Inc. Business Overview
  58. 6.10.3 Epiphany Biosciences, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Product Portfolio
  60. 6.10.5 Epiphany Biosciences, Inc. Recent Developments
  61. 6.11 ContraVir Pharmaceuticals, Inc.
  62. 6.11.1 ContraVir Pharmaceuticals, Inc. Company Information
  63. 6.11.2 ContraVir Pharmaceuticals, Inc. Business Overview
  64. 6.11.3 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Product Portfolio
  66. 6.11.5 ContraVir Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Herpes Zoste Drug Sales by Country
  2. 7.1.1 North America Herpes Zoste Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Herpes Zoste Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Herpes Zoste Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Herpes Zoste Drug Market Size by Country
  6. 7.2.1 North America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Herpes Zoste Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Herpes Zoste Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Herpes Zoste Drug Sales by Country
  2. 8.1.1 Europe Herpes Zoste Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Herpes Zoste Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Herpes Zoste Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Herpes Zoste Drug Market Size by Country
  6. 8.2.1 Europe Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Herpes Zoste Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Herpes Zoste Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Herpes Zoste Drug Sales by Country
  2. 9.1.1 Asia-Pacific Herpes Zoste Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Herpes Zoste Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Herpes Zoste Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Herpes Zoste Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Herpes Zoste Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Herpes Zoste Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Herpes Zoste Drug Sales by Country
  2. 10.1.1 South America Herpes Zoste Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Herpes Zoste Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Herpes Zoste Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Herpes Zoste Drug Market Size by Country
  6. 10.2.1 South America Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Herpes Zoste Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Herpes Zoste Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Herpes Zoste Drug Sales by Country
  2. 11.1.1 Middle East and Africa Herpes Zoste Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Herpes Zoste Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Herpes Zoste Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Herpes Zoste Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Herpes Zoste Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Herpes Zoste Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Herpes Zoste Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Herpes Zoste Drug Value Chain Analysis
  2. 12.1.1 Herpes Zoste Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Herpes Zoste Drug Production Mode & Process
  7. 12.2 Herpes Zoste Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Herpes Zoste Drug Distributors
  10. 12.2.3 Herpes Zoste Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst